fashion -WSS

fashion

author：leisure time 2025-09-03 03:27:40 - browse：8495

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Does Paxlovid work in people vaccinated against Covid

hotspot

WSS

Allen Institute goes after foundational questions, CEO Costa says

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

International team creates first chimeric human

Fauci's latest grilling in Congress: 9 hours, behind closed doors

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

ALS groups 'won't be played again' by the FDA, drug sponsors

explore

fashion

focus

What does generative AI mean for health care? We asked experts

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Supreme Court strikes down use of affirmative action

A Q&A with Aletha Maybank, AMA’s chief health equity officer

The cancer drug shortage isn’t new — and neither are the solutions

STAT Virtual Event: JPM Recap, Live!

What does generative AI mean for health care? We asked experts

FDA early review: GLP

Continuity nursing helped my family in our darkest PICU moments

Stories you might have missed in 2023: health, science, medicine

hotspot

Medicare Advantage coverage denials need scrutiny, senators say

Physician assistants need a new name. Here's what it should be

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

JPM pitch from hospitals? Revenue streams outside of patient care

House looks to weaken Medicare negotiation

hotspot

hotspot

explore

focus